Produced by Bayer Pharma to compete with Pfizer Pharma's Revolution, Advantage Multi ® aka aka Advocate Spot On ® is a product which
combines imidacloprid for flea control and moxidectin for heartworm prevention in one product.
This product
combines imidacloprid and pyriproxyfen to kill adult fleas, flea eggs, and larvae.
Not exact matches
In Advantage Multi, it is
combined with
imidacloprid, a flea - killing topical, to create a product used against heartworm, hookworm, roundworm, whipworm, and fleas.
Advantage Multi ®
combines moxidectin with
imidacloprid, the flea - killing ingredient in Advantage ®, to create a broad spectrum anti-parasite product for both dogs and cats.
Although moxidectin is in the same drug family as ivermectin, some veterinarians use it,
combined with
imidacloprid (Advantage Multi ®) to treat mange successfully — even in dogs with the MDR1 aka ABCB1 gene mutation.
Although moxidectin is in the same drug family as ivermectin, some veterinarians use it,
combined with
imidacloprid (Advantage Multi ® aka aka Advocate Spot On ®) to treat mange successfully — even in dogs with the MDR1 aka ABCB1 gene mutation.